GB9811836D0 - Gene therapy method - Google Patents

Gene therapy method

Info

Publication number
GB9811836D0
GB9811836D0 GBGB9811836.7A GB9811836A GB9811836D0 GB 9811836 D0 GB9811836 D0 GB 9811836D0 GB 9811836 A GB9811836 A GB 9811836A GB 9811836 D0 GB9811836 D0 GB 9811836D0
Authority
GB
United Kingdom
Prior art keywords
gene therapy
therapy method
gene
therapy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9811836.7A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GBGB9811836.7A priority Critical patent/GB9811836D0/en
Publication of GB9811836D0 publication Critical patent/GB9811836D0/en
Priority to TR2001/00348T priority patent/TR200100348T2/en
Priority to APAP/P/2000/001999A priority patent/AP2000001999A0/en
Priority to PT99925174T priority patent/PT1083934E/en
Priority to PCT/GB1999/001722 priority patent/WO1999062561A2/en
Priority to AT99925174T priority patent/ATE246518T1/en
Priority to CA002334171A priority patent/CA2334171A1/en
Priority to CN99809287A priority patent/CN1311822A/en
Priority to DE69910202T priority patent/DE69910202T2/en
Priority to PL99345207A priority patent/PL345207A1/en
Priority to EP02020179A priority patent/EP1281763A3/en
Priority to YU75600A priority patent/YU75600A/en
Priority to EA200001124A priority patent/EA200001124A1/en
Priority to EP99925174A priority patent/EP1083934B1/en
Priority to KR1020007013584A priority patent/KR20010043968A/en
Priority to JP2000551815A priority patent/JP2002516676A/en
Priority to SI9930418T priority patent/SI1083934T1/en
Priority to IL13993699A priority patent/IL139936A0/en
Priority to ES99925174T priority patent/ES2205830T3/en
Priority to HU0103252A priority patent/HUP0103252A3/en
Priority to SK1832-2000A priority patent/SK18322000A3/en
Priority to US09/701,749 priority patent/US6689758B1/en
Priority to DK99925174T priority patent/DK1083934T3/en
Priority to NZ508505A priority patent/NZ508505A/en
Priority to AU41560/99A priority patent/AU770497B2/en
Priority to BR9910877-1A priority patent/BR9910877A/en
Priority to EEP200000790A priority patent/EE200000790A/en
Priority to TR2001/02985T priority patent/TR200102985T2/en
Priority to IDW20002711A priority patent/ID27483A/en
Priority to ZA200006963A priority patent/ZA200006963B/en
Priority to IS5742A priority patent/IS5742A/en
Priority to NO20006047A priority patent/NO20006047L/en
Priority to HR20000832A priority patent/HRP20000832A2/en
Priority to HK01105197A priority patent/HK1034465A1/en
Ceased legal-status Critical Current

Links

GBGB9811836.7A 1998-06-02 1998-06-02 Gene therapy method Ceased GB9811836D0 (en)

Priority Applications (34)

Application Number Priority Date Filing Date Title
GBGB9811836.7A GB9811836D0 (en) 1998-06-02 1998-06-02 Gene therapy method
IDW20002711A ID27483A (en) 1998-06-02 1999-06-02 GENERAL THERAPY METHOD
SI9930418T SI1083934T1 (en) 1998-06-02 1999-06-02 EGR-1 for the manufacture of a medicament for treating wounds
ES99925174T ES2205830T3 (en) 1998-06-02 1999-06-02 EGR-1 FOR THE PREPARATION OF A MEDICINAL PRODUCT TO TREAT WOUNDS.
PT99925174T PT1083934E (en) 1998-06-02 1999-06-02 EGR-1 FOR THE PRODUCTION OF A WOUND TREATMENT MEDICINE
PCT/GB1999/001722 WO1999062561A2 (en) 1998-06-02 1999-06-02 Gene therapy method
IL13993699A IL139936A0 (en) 1998-06-02 1999-06-02 Gene therapy method
CA002334171A CA2334171A1 (en) 1998-06-02 1999-06-02 Gene therapy method
CN99809287A CN1311822A (en) 1998-06-02 1999-06-02 Gene therapy method
APAP/P/2000/001999A AP2000001999A0 (en) 1998-06-02 1999-06-02 Gene therapy method.
PL99345207A PL345207A1 (en) 1998-06-02 1999-06-02 Gene therapy method
HU0103252A HUP0103252A3 (en) 1998-06-02 1999-06-02 Gene therapy method
YU75600A YU75600A (en) 1998-06-02 1999-06-02 Application of polypeptides of e
EA200001124A EA200001124A1 (en) 1998-06-02 1999-06-02 METHOD OF GENE THERAPY
EP99925174A EP1083934B1 (en) 1998-06-02 1999-06-02 EGR-1 for the manufacture of a medicament for treating wounds
KR1020007013584A KR20010043968A (en) 1998-06-02 1999-06-02 Gene Therapy Method
JP2000551815A JP2002516676A (en) 1998-06-02 1999-06-02 Gene therapy
TR2001/00348T TR200100348T2 (en) 1998-06-02 1999-06-02 Gene therapy techniques
AT99925174T ATE246518T1 (en) 1998-06-02 1999-06-02 EGR-1 FOR PRODUCING A MEDICATION FOR THE TREATMENT OF WOUNDS
DE69910202T DE69910202T2 (en) 1998-06-02 1999-06-02 EGR-1 for the manufacture of a medicament for the treatment of wounds
EP02020179A EP1281763A3 (en) 1998-06-02 1999-06-02 Early growth response-1 (EGR-1) transcription factor
SK1832-2000A SK18322000A3 (en) 1998-06-02 1999-06-02 Use of nucleic acid molecule, pharmaceutical composition containing it and a nucleic acid molecule
US09/701,749 US6689758B1 (en) 1998-06-02 1999-06-02 Gene therapy method
DK99925174T DK1083934T3 (en) 1998-06-02 1999-06-02 gene Therapy Methods
NZ508505A NZ508505A (en) 1998-06-02 1999-06-02 Treatment of wounds using an Egr-1 transcription factor polypeptide
AU41560/99A AU770497B2 (en) 1998-06-02 1999-06-02 Gene therapy method
BR9910877-1A BR9910877A (en) 1998-06-02 1999-06-02 Use of a nucleic acid molecule and a polypeptide, nucleic acid molecule, pharmaceutical composition, polypeptide, nucleic acid vector, cell, wound treatment processes in a mammal and a patient, diagnosis, selection, identification of an agent capable of supra-regular or infra-regular transcription of egr-1, and, agent
EEP200000790A EE200000790A (en) 1998-06-02 1999-06-02 Gene therapy method
TR2001/02985T TR200102985T2 (en) 1998-06-02 1999-06-02 Gene therapy techniques.
ZA200006963A ZA200006963B (en) 1998-06-02 2000-11-27 Gene therapy method.
IS5742A IS5742A (en) 1998-06-02 2000-11-28 Method of gene therapy
NO20006047A NO20006047L (en) 1998-06-02 2000-11-29 Procedures for gene therapy
HR20000832A HRP20000832A2 (en) 1998-06-02 2000-12-01 Gene therapy method
HK01105197A HK1034465A1 (en) 1998-06-02 2001-07-24 Egr-1 for the manufacturing of a medicament for treating wounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9811836.7A GB9811836D0 (en) 1998-06-02 1998-06-02 Gene therapy method

Publications (1)

Publication Number Publication Date
GB9811836D0 true GB9811836D0 (en) 1998-07-29

Family

ID=10833071

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9811836.7A Ceased GB9811836D0 (en) 1998-06-02 1998-06-02 Gene therapy method

Country Status (2)

Country Link
GB (1) GB9811836D0 (en)
ZA (1) ZA200006963B (en)

Also Published As

Publication number Publication date
ZA200006963B (en) 2002-01-02

Similar Documents

Publication Publication Date Title
GB9622500D0 (en) Therapeutic gene
EP1077996A4 (en) HUMAN EDG3sb GENE
HUP0103252A3 (en) Gene therapy method
GB9816556D0 (en) Therapy
HUP0104046A3 (en) Adenovirus-mediated gene therapy
GB9719161D0 (en) New therapeutic method
GB9714841D0 (en) Treatment method
GB9924981D0 (en) Gene therapy
GB9900009D0 (en) Gene therapy
GB9811836D0 (en) Gene therapy method
GB9819846D0 (en) Gene therapy method
GB9819826D0 (en) Gene therapy method
GB9815035D0 (en) Gene therapy method
GB9814989D0 (en) Gene therapy method
GB9706469D0 (en) Genetic method
GB0406539D0 (en) Gene therapy
GB9719176D0 (en) New therapeutic method
GB9719189D0 (en) New therapeutic method
GB9804285D0 (en) Therapeutic method
GB9800683D0 (en) Therapeutic method
GB9806039D0 (en) Therapy
GB9826753D0 (en) Genetic method
GB9818001D0 (en) Genetic method
GB9719167D0 (en) New therapeutic method
GB9719163D0 (en) New therapeutic method

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)